CURLD (Curaleaf Holdings) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 24, 2026)


CURLD Curaleaf Holdings Inc CURLD
67 GF Score
Price $9.33
GF Value $8.11
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Curaleaf Holdings Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Curaleaf Holdings's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.


CURLD vs ZTS: Margin of Safety % (DCF FCF Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Curaleaf Holdings's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Curaleaf Holdings Margin of Safety % (DCF FCF Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Curaleaf Holdings's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Curaleaf Holdings's Margin of Safety % (DCF FCF Based) falls into.


CURLD
67GF Score
Curaleaf Holdings Inc CURLD
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Curaleaf Holdings (CURLD) Overvalued in 2026?

Based on GuruFocus' analysis, Curaleaf Holdings stock appears to be overvalued. The current stock price of $9.33 is trading 15% above its estimated GF Value™ of $8.11. GuruFocus considers Curaleaf Holdings to be Modestly Overvalued.

Key valuation signals for CURLD:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: $8.11 vs. price of $9.33 (15% above fair value)
  • GF Score™: 67/100 with 5 warning signs

No single metric tells the full story. See the CURLD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Curaleaf Holdings Business Description

Other Exchanges 2XW:GermanyCURA:Canada
Address 290 Harbor Drive, Stamford, CT, USA, 06902
Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the US. The company has operations in 17 states. Its brands include Curaleaf, Select, and Grassroots. The company has made acquisitions that give it exposure to the growing European market, a unique feature among US multistate operators.
67GF Score

Get the complete analysis for CURLD

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.33
Price
$8.11
GF Value